Sales Changement Date
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Akebia Therapeutics USD 56.2M 14.15M 2023-12
Amgen USD 8.2B 1.29B 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Bayer EUR 11.86B 1.52B 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Cytokinetics USD 1.67M 1.29M 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Esperion Therapeutics USD 32.25M 1.72M 2023-12
Exelixis USD 479.65M 7.73M 2023-12
Genmab DKK 4.68B 66M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 14.63B 1.33B 2023-12
Moderna USD 2.81B 980M 2023-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Puma Biotechnology USD 72.18M 16.06M 2023-12
Sanofi EUR 11.75B 1.26B 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Exelixis Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.